Financial statements Chemoform Polska
Balance sheet data of CHEMOFORM POLSKA
|
Year
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|---|
| Total assets | 6 674 533,59 | 8 962 045,29 | 9 310 714,16 | 11 791 412,53 | 12 331 332,09 | 11 541 602,67 |
| A. Fixed assets | 554 826,89 | 579 476,99 | 577 200,70 | 1 826 908,72 | 1 858 405,57 | 1 886 474,60 |
| B. Current assets | 6 119 706,70 | 8 382 568,30 | 8 733 513,46 | 9 964 503,81 | 10 472 926,52 | 9 655 128,07 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 6 674 533,59 | 8 962 045,29 | 9 310 714,16 | 11 791 412,53 | 12 331 332,09 | 11 541 602,67 |
| A. Equity | 5 877 120,62 | 6 697 182,73 | 8 130 916,25 | 8 498 321,03 | 9 407 004,28 | 9 818 040,34 |
| B. Liabilities and provisions for liabilities | 797 412,97 | 2 264 862,56 | 1 179 797,91 | 3 293 091,50 | 2 924 327,81 | 1 723 562,33 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 395 822,00 | 145 814,00 | 0,00 |
| II. Short-term liabilities | 519 729,44 | 1 916 178,77 | 1 100 578,36 | 2 500 120,33 | 2 318 344,60 | 1 278 988,45 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.